# Phase 1, Open-label Study of the Absorption, Metabolism, and Excretion of [14C]-KW-6356

> **NCT04147910** · PHASE1 · COMPLETED · sponsor: **Kyowa Kirin, Inc.** · enrollment: 8 (actual)

## Conditions studied

- Healthy Male Subjects

## Interventions

- **DRUG:** KW-6356

## Key facts

- **NCT ID:** NCT04147910
- **Lead sponsor:** Kyowa Kirin, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-08-21
- **Primary completion:** 2019-10-02
- **Final completion:** 2019-10-02
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2024-04-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04147910

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04147910, "Phase 1, Open-label Study of the Absorption, Metabolism, and Excretion of [14C]-KW-6356". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04147910. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*